A case of pneumocystis pneumonia after Cetuximab-based bioradiotherapy

Asano Shinohara, Ryunosuke Kogo, Hideoki Uryu, Ryuji Yasumatsu, Torahiko Nakashima, Shizuo Komune

研究成果: Contribution to journalArticle査読

2 被引用数 (Scopus)

抄録

Reports of drug-induced interstitial pneumonia caused by Cetuximab have been increasing. Pneumocystis pneumonia is important as a differential diagnosis of drug-induced interstitial pneumonia. We report herein on a 64-year-old man with pneumocystis pneumonia after cetuximab-based bioradiotherapy for laryngeal cancer. After radiotherapy, the patient developed multi-drug resistant pneumonia. Chest CT imaging revealed diffuse ground-glass opacities in the lung field. He was diagnosed as having pneumocystis pneumonia based on the bronchoalveolar lavage (BAL) findings, and then his symptoms improved after treatment with Trimethoprim/Sulfamethoxazole. It is important to assess the risk factor for pneumocystis pneumonia for early its detection and treatment.

本文言語英語
ページ(範囲)204-209
ページ数6
ジャーナルJournal of Otolaryngology of Japan
119
3
DOI
出版ステータス出版済み - 2016

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology

フィンガープリント 「A case of pneumocystis pneumonia after Cetuximab-based bioradiotherapy」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル